In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity.
Zhou P, Gao G, Zhao CC, Li JY, Peng JF, Wang SS, Song R, Shi H, Wang L.
Zhou P, et al.
Pharm Biol. 2022 Dec;60(1):638-651. doi: 10.1080/13880209.2022.2046801.
Pharm Biol. 2022.
PMID: 35298357
Free PMC article.
MATERIALS AND METHODS: In vivo, DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-L (2.7 mL/kg), SMI-M (5.4 mL/kg), and SMI-H (10.8 mL/kg) for 7 consecutive days. ...Compared with the model group, the protein expression of nuclear factor erythr …
MATERIALS AND METHODS: In vivo, DOX (15 mg/kg) was intraperitoneally injected in model, Dex (dexrazoxane), SMI-L (2.7 mL/kg), SMI-M ( …